Ataxia-telangiectasia (A-T) is a rare disorder caused by genetic defects of A-T mutated (ATM) kinase, a key regulator of stress response, and characterized by neurodegeneration, immunodeficiency, and high incidence of cancer. Here we investigated NK cells in a mouse model of A-T (Atm− /− ) showing that they are strongly impaired at killing tumor cells due to a block of early signaling events. On the other hand, in Atm− /− littermates with thymic lymphoma NK cell cytotoxicity is enhanced as compared with ATM-proficient mice, possibly via tumor- produced TNF-α. Results also suggest that expansion of exhausted NKG2D+ NK cells in Atm− /− mice is driven by low-level expression of stress-inducible NKG2D ligands, whereas development of thymoma expressing the high- affinity MULT1 ligand is associated with NKG2D down-regulation on NK cells. These results expand our understanding of immunodeficiency in A-T and encourage exploring NK cell biology in A-T patients in the attempt to identify cancer predictive biomarkers and novel therapeutic targets.

Absence of ATM leads to altered NK cell function in mice

Alessandro Giovinazzo;Daniela Marazziti;Manuela Pellegrini;
2024

Abstract

Ataxia-telangiectasia (A-T) is a rare disorder caused by genetic defects of A-T mutated (ATM) kinase, a key regulator of stress response, and characterized by neurodegeneration, immunodeficiency, and high incidence of cancer. Here we investigated NK cells in a mouse model of A-T (Atm− /− ) showing that they are strongly impaired at killing tumor cells due to a block of early signaling events. On the other hand, in Atm− /− littermates with thymic lymphoma NK cell cytotoxicity is enhanced as compared with ATM-proficient mice, possibly via tumor- produced TNF-α. Results also suggest that expansion of exhausted NKG2D+ NK cells in Atm− /− mice is driven by low-level expression of stress-inducible NKG2D ligands, whereas development of thymoma expressing the high- affinity MULT1 ligand is associated with NKG2D down-regulation on NK cells. These results expand our understanding of immunodeficiency in A-T and encourage exploring NK cell biology in A-T patients in the attempt to identify cancer predictive biomarkers and novel therapeutic targets.
2024
Istituto di Biochimica e Biologia Cellulare - IBBC - Sede Secondaria Monterotondo
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1521661624003425-main.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 5.77 MB
Formato Adobe PDF
5.77 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/471481
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact